As CQDM’s key initiative, the Quantum Leap Funding Program was created to help small to-medium-sized-enterprises (SMEs) and Canadian universities with funding to work on cutting-edge, innovative pharmaceutical research projects with the overall goal of discovering cleaner and more efficient drug options.
- Amount: Grants up to 50-66% to a maximum of $1,200,000 per eligible project.
- Timeline: Application are accepted year-round. The deadline to participate in the next selection round is November 26, 2020.
- Eligibility: Canadian SMEs with less than 500 employees, and public research institutions in Canada.
- Eligible Projects: Innovative research and development drug discovery projects with potential impact on drug research, scientific excellence, commercial potential, and economic benefits.
Recent Quantum Leap Funding Program News:
Posted: September 17, 2020